Quest Diagnostics EBITDA Margin 2010-2024 | DGX

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Quest Diagnostics (DGX) over the last 10 years. The current EBITDA margin for Quest Diagnostics as of March 31, 2024 is .
Quest Diagnostics EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2024-03-31 $9.29B $1.71B 18.36%
2023-12-31 $9.25B $1.70B 18.39%
2023-09-30 $9.30B $1.58B 16.95%
2023-06-30 $9.49B $1.62B 17.11%
2023-03-31 $9.60B $1.66B 17.27%
2022-12-31 $9.88B $1.87B 18.87%
2022-09-30 $10.29B $2.26B 21.92%
2022-06-30 $10.58B $2.51B 23.71%
2022-03-31 $10.68B $2.65B 24.79%
2021-12-31 $10.79B $2.79B 25.85%
2021-09-30 $11.05B $3.04B 27.52%
2021-06-30 $11.06B $3.09B 27.98%
2021-03-31 $10.34B $2.83B 27.41%
2020-12-31 $9.44B $2.33B 24.71%
2020-09-30 $8.36B $1.88B 22.53%
2020-06-30 $7.53B $1.47B 19.55%
2020-03-31 $7.66B $1.49B 19.43%
2019-12-31 $7.73B $1.56B 20.19%
2019-09-30 $7.64B $1.42B 18.54%
2019-06-30 $7.57B $1.40B 18.52%
2019-03-31 $7.54B $1.40B 18.52%
2018-12-31 $7.53B $1.41B 18.72%
2018-09-30 $7.56B $1.45B 19.20%
2018-06-30 $7.52B $1.44B 19.10%
2018-03-31 $7.47B $1.44B 19.28%
2017-12-31 $7.40B $1.44B 19.39%
2017-09-30 $7.10B $1.43B 20.18%
2017-06-30 $7.13B $1.45B 20.35%
2017-03-31 $7.17B $1.55B 21.60%
2016-12-31 $7.21B $1.53B 21.15%
2016-09-30 $7.50B $1.50B 19.99%
2016-06-30 $7.50B $1.82B 24.31%
2016-03-31 $7.52B $1.72B 22.83%
2015-12-31 $7.49B $1.70B 22.73%
2015-09-30 $7.53B $1.73B 22.93%
2015-06-30 $7.55B $1.35B 17.92%
2015-03-31 $7.53B $1.32B 17.53%
2014-12-31 $7.44B $1.30B 17.44%
2014-09-30 $7.31B $1.30B 17.83%
2014-06-30 $7.19B $1.73B 24.00%
2014-03-31 $7.11B $1.74B 24.55%
2013-12-31 $7.15B $1.76B 24.60%
2013-09-30 $7.16B $1.75B 24.47%
2013-06-30 $7.20B $1.37B 19.05%
2013-03-31 $7.26B $1.42B 19.49%
2012-12-31 $7.38B $1.49B 20.15%
2012-09-30 $7.37B $1.54B 20.90%
2012-06-30 $7.45B $1.56B 20.91%
2012-03-31 $7.48B $1.54B 20.64%
2011-12-31 $7.39B $1.27B 17.15%
2011-09-30 $7.35B $1.23B 16.68%
2011-06-30 $7.31B $1.23B 16.85%
2011-03-31 $7.28B $1.27B 17.45%
2010-12-31 $7.26B $1.54B 21.18%
2010-09-30 $7.39B $1.59B 21.44%
2010-06-30 $7.43B $1.60B 21.49%
2010-03-31 $7.45B $1.59B 21.36%
2009-12-31 $7.46B $1.62B 21.68%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $15.695B $9.252B
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $17.537B 10.61
DaVita (DVA) United States $12.150B 15.09
Encompass Health (EHC) United States $8.507B 21.78
Chemed (CHE) United States $8.408B 26.06
Elanco Animal Health (ELAN) United States $8.297B 21.53
Option Care Health (OPCH) United States $5.048B 19.11
RadNet (RDNT) United States $4.325B 90.06
Amedisys (AMED) United States $3.145B 22.28
Astrana Health (ASTH) United States $2.239B 30.28
LifeStance Health (LFST) United States $2.179B 0.00
Addus HomeCare (ADUS) United States $1.827B 26.14
U.S Physical Therapy (USPH) United States $1.534B 41.06
Pennant (PNTG) United States $0.706B 37.29
Aveanna Healthcare Holdings (AVAH) United States $0.539B 0.00
Atai Life Sciences (ATAI) Germany $0.270B 0.00
Daxor (DXR) United States $0.045B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.026B 0.00
ATI Physical Therapy (ATIP) United States $0.021B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Ontrak (OTRK) United States $0.013B 0.00
Novo Integrated Sciences (NVOS) United States $0.010B 0.00
IMAC Holdings (BACK) United States $0.004B 0.00